Published in PLoS One on December 26, 2012
Infection prevention and control standards in assisted living facilities: are residents' needs being met? J Am Med Dir Assoc (2013) 0.79
Is hepatitis B-virucidal validation of biocides possible with the use of surrogates? World J Gastroenterol (2014) 0.75
Demonstration of disinfection procedure for the development of accurate blood glucose meters in accordance with ISO 15197:2013. PLoS One (2017) 0.75
The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol (1987) 266.90
MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol (2011) 220.97
Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep (2008) 6.02
Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology (2002) 2.79
Infection control assessment of ambulatory surgical centers. JAMA (2010) 2.74
Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ (2009) 2.69
Survival of hepatitis B virus after drying and storage for one week. Lancet (1981) 2.60
Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Ann Intern Med (2009) 2.28
Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci U S A (1991) 2.05
Nosocomial transmission of hepatitis B virus associated with the use of a spring-loaded finger-stick device. N Engl J Med (1992) 1.85
Natural history and prognostic factors for chronic hepatitis type B. Gut (1991) 1.75
Eliminating the blood: ongoing outbreaks of hepatitis B virus infection and the need for innovative glucose monitoring technologies. J Diabetes Sci Technol (2009) 1.72
Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep (2011) 1.57
Assisted monitoring of blood glucose: special safety needs for a new paradigm in testing glucose. J Diabetes Sci Technol (2010) 1.48
Viral hepatitis transmission in ambulatory health care settings. Clin Infect Dis (2004) 1.44
Acute hepatitis B outbreaks related to fingerstick blood glucose monitoring in two assisted living facilities. J Am Geriatr Soc (2010) 1.22
Epidemic history and evolutionary dynamics of hepatitis B virus infection in two remote communities in rural Nigeria. PLoS One (2010) 1.17
Transmission of hepatitis B virus among persons undergoing blood glucose monitoring in long-term-care facilities--Mississippi, North Carolina, and Los Angeles County, California, 2003-2004. MMWR Morb Mortal Wkly Rep (2005) 1.16
US outbreak investigations highlight the need for safe injection practices and basic infection control. Clin Liver Dis (2010) 1.15
Evaluation of the potential for bloodborne pathogen transmission associated with diabetes care practices in nursing homes and assisted living facilities, Pinellas County. J Am Geriatr Soc (2010) 1.14
Infection control practices in assisted living facilities: a response to hepatitis B virus infection outbreaks. Infect Control Hosp Epidemiol (2009) 1.11
Notes from the field: deaths from acute hepatitis B virus infection associated with assisted blood glucose monitoring in an assisted-living facility--North Carolina, August-October 2010. MMWR Morb Mortal Wkly Rep (2011) 1.02
Nosocomial hepatitis B virus infection associated with reusable fingerstick blood sampling devices--Ohio and New York City, 1996. MMWR Morb Mortal Wkly Rep (1997) 0.97
Nosocomial transmission of hepatitis B virus associated with a spring-loaded fingerstick device--California. MMWR Morb Mortal Wkly Rep (1990) 0.96
Predictors of organizational commitment among staff in assisted living. Gerontologist (2005) 0.94
An empirical typology of residential care/assisted living based on a four-state study. Gerontologist (2006) 0.91
Deja vu: nosocomial hepatitis B virus transmission and fingerstick monitoring. Am J Med (1998) 0.91
Evaluation of intra-host variants of the entire hepatitis B virus genome. PLoS One (2011) 0.85
Transmission of hepatitis B virus associated with assisted monitoring of blood glucose at an assisted living facility in New York State. Am J Infect Control (2012) 0.85
Multiple outbreaks of hepatitis B virus infection related to assisted monitoring of blood glucose among residents of assisted living facilities--Virginia, 2009-2011. MMWR Morb Mortal Wkly Rep (2012) 0.83
Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr (2006) 12.07
Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med (2003) 8.05
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med (2008) 7.71
Health care-associated invasive MRSA infections, 2005-2008. JAMA (2010) 4.79
Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med (2014) 3.50
Vascular access hemorrhages contribute to deaths among hemodialysis patients. Kidney Int (2012) 3.40
Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med (2008) 3.16
Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis (2008) 2.95
Hepatitis C in the United States. N Engl J Med (2013) 2.63
Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis (2003) 2.58
Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clin Infect Dis (2010) 2.57
Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet (2002) 2.50
Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition. Infect Control Hosp Epidemiol (2013) 2.28
Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Ann Intern Med (2009) 2.28
Fungal infections associated with contaminated methylprednisolone in Tennessee. N Engl J Med (2012) 2.16
Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence. Clin Infect Dis (2012) 2.15
Hepatitis B virus transmissions associated with a portable dental clinic, West Virginia, 2009. J Am Dent Assoc (2013) 2.07
Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients. AIDS (2002) 1.99
Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis (2004) 1.91
The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy. AIDS (2006) 1.88
The evolving epidemiology of hepatitis a in the United States: incidence and molecular epidemiology from population-based surveillance, 2005-2007. Arch Intern Med (2010) 1.88
Health care-associated hepatitis C virus infections attributed to narcotic diversion. Ann Intern Med (2012) 1.71
The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study. Ann Intern Med (2009) 1.69
Multistate outbreak of Escherichia coli O157:H7 infection associated with consumption of packaged spinach, August-September 2006: the Wisconsin investigation. Clin Infect Dis (2009) 1.66
Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients. J Acquir Immune Defic Syndr (2003) 1.65
Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005. AIDS (2008) 1.63
Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient Study. J Int Assoc Physicians AIDS Care (Chic) (2007) 1.59
Hepatitis C virus infections from unsafe injection practices at an endoscopy clinic in Las Vegas, Nevada, 2007-2008. Clin Infect Dis (2010) 1.57
Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination. J Infect Dis (2008) 1.57
Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis. J Am Acad Dermatol (2007) 1.55
Antimicrobial use in outpatient hemodialysis units. Infect Control Hosp Epidemiol (2013) 1.46
Factors associated with chronic renal failure in HIV-infected ambulatory patients. AIDS (2004) 1.45
Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med (2005) 1.43
Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010. Clin Infect Dis (2014) 1.43
Prevalence and clinical correlates of HIV viremia ('blips') in patients with previous suppression below the limits of quantification. AIDS (2002) 1.42
Transmission of hepatitis B virus from an orthopedic surgeon with a high viral load. Clin Infect Dis (2012) 1.41
Hepatitis E epidemic, Uganda. Emerg Infect Dis (2010) 1.41
Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infect Control Hosp Epidemiol (2009) 1.38
Efficient error correction for next-generation sequencing of viral amplicons. BMC Bioinformatics (2012) 1.38
Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency. J Acquir Immune Defic Syndr (2008) 1.36
A novel hepacivirus with an unusually long and intrinsically disordered NS5A protein in a wild Old World primate. J Virol (2013) 1.30
End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: performance under optimal and suboptimal conditions. J Virol Methods (2008) 1.28
Laboratory diagnostics for hepatitis C virus infection. Clin Infect Dis (2012) 1.25
Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort. Clin Infect Dis (2013) 1.20
Patient notification for bloodborne pathogen testing due to unsafe injection practices in the US health care settings, 2001-2011. Med Care (2012) 1.16
US outbreak investigations highlight the need for safe injection practices and basic infection control. Clin Liver Dis (2010) 1.15
Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. J Infect Dis (2011) 1.13
Preventing catheter-related bloodstream infections outside the intensive care unit: expanding prevention to new settings. Clin Infect Dis (2010) 1.12
Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients. J Acquir Immune Defic Syndr (2006) 1.12
Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients. Am J Kidney Dis (2010) 1.11
Infection control practices in assisted living facilities: a response to hepatitis B virus infection outbreaks. Infect Control Hosp Epidemiol (2009) 1.11
Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis (2004) 1.11
An assessment of the performance of self-reported vaccination status for hepatitis B, National Health and Nutrition Examination Survey 1999-2008. Am J Public Health (2013) 1.08
Locally acquired hepatitis E virus infection, El Paso, Texas. J Med Virol (2006) 1.08
Restricted enzooticity of hepatitis E virus genotypes 1 to 4 in the United States. J Clin Microbiol (2011) 1.07
One-step real-time PCR assay for detection and quantitation of hepatitis D virus RNA. J Virol Methods (2013) 1.07
Outbreak of carbapenem-resistant enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions. Infect Control Hosp Epidemiol (2012) 1.07
Association of standing-order policies with vaccination rates in dialysis clinics: a US-based cross-sectional study. Am J Kidney Dis (2009) 1.06
Spatial configuration of hepatitis E virus antigenic domain. J Virol (2010) 1.05
Infections in long-term care populations in the United States. J Am Geriatr Soc (2013) 1.05
Trends in hepatitis C virus infection among patients in the HIV Outpatient Study, 1996-2007. J Acquir Immune Defic Syndr (2010) 1.04
Decreasing listeriosis mortality in the United States, 1990-2005. Clin Infect Dis (2008) 1.03
Invasive methicillin-resistant Staphylococcus aureus infections among patients on chronic dialysis in the United States, 2005-2011. Clin Infect Dis (2013) 1.02
Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study. J Clin Virol (2012) 1.02
Vulnerable populations and the association between periodontal and chronic kidney disease. Clin J Am Soc Nephrol (2011) 0.99
Novel risk factors associated with hepatitis E virus infection in a large outbreak in northern Uganda: results from a case-control study and environmental analysis. Am J Trop Med Hyg (2010) 0.98
Immunity to hepatitis B virus (HBV) infection two decades after implementation of universal infant HBV vaccination: association of detectable residual antibodies and response to a single HBV challenge dose. Clin Vaccine Immunol (2013) 0.97
Hepatitis E virus infection in HIV-infected persons. Emerg Infect Dis (2012) 0.96
Outbreak of acute hepatitis B virus infections associated with podiatric care at a psychiatric long-term care facility. Am J Infect Control (2011) 0.94
Hepatitis C virus transmission in hemodialysis units: importance of infection control practices and aseptic technique. Infect Control Hosp Epidemiol (2009) 0.93
Coevolution of the hepatitis C virus polyprotein sites in patients on combined pegylated interferon and ribavirin therapy. J Virol (2011) 0.92
Next-generation sequencing reveals large connected networks of intra-host HCV variants. BMC Genomics (2014) 0.92
Seroprevalence of hepatitis A virus antibodies in the U.S.: results from the National Health and Nutrition Examination Survey. Public Health Rep (2011) 0.91
SARS clinical features, United States, 2003. Emerg Infect Dis (2005) 0.91
Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: the Chronic Hepatitis Cohort Study (CHeCS). Hepatology (2015) 0.91
Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study. Am J Kidney Dis (2008) 0.90
Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up. Hepatology (2012) 0.90
Disparate distribution of hepatitis B virus genotypes in four sub-Saharan African countries. J Clin Virol (2013) 0.89
Persistence of long-term immunity to hepatitis B among adolescents immunized at birth. Vaccine (2012) 0.89
Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities. Vaccine (2011) 0.89
Hepatitis C virus antigenic convergence. Sci Rep (2012) 0.89
Central nervous system and eye manifestations of infection with Baylisascaris procyonis. Curr Infect Dis Rep (2006) 0.88
Convergence and coevolution of hepatitis B virus drug resistance. Nat Commun (2012) 0.88
Improved anamnestic response among adolescents boosted with a higher dose of the hepatitis B vaccine. Vaccine (2010) 0.87
An investigation of bloodborne pathogen transmission due to multipatient sharing of insulin pens. Mil Med (2012) 0.87
Hepatitis B outbreak associated with a hematology-oncology office practice in New Jersey, 2009. Am J Infect Control (2011) 0.86
New Calicivirus isolated from walrus. Virus Res (2004) 0.86
Launch of a Nationwide Hepatitis C Elimination Program--Georgia, April 2015. MMWR Morb Mortal Wkly Rep (2015) 0.85
Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak. Vaccine (2012) 0.85